Table 2.
Activity | Active Compound | Mechanism of Action | References |
---|---|---|---|
Anti-inflammatory | GOPO (1,2-di-O-α-linolenoyl-3-O-β-d-galactopyranosyl-sn-glycerol) | Reduction in peripheral blood polymorphonuclear leukocytes, neutrophils and monocytes migration Reduction in the levels of C-reactive protein (CRP) |
Larsen et al. [61] Winther et al. [105] Kharazmi et al. [102] |
Fatty acids (triterpenoic acids, ursolic acid, oleanolic acid and betulinic acid) | Inhibition of COX-1 and COX-2 | Jäger et al. [109] Wenzing et al. [110] |
|
Reduction in pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, (IFN)-γ, IL-12) and chemokines CCL5 (RANTES), IP-10 (CXCL10) production | Yan et al. [106] Schwager et al. [107,108] |
||
Inhibition of NF-κB related inflammatory response | Phytosterols β-sitosterol |
Attenuation of NF-κB phosphorylation | Whang et al. [115] |
Gallic acid | Reestablishment IκBα and NF-κB association | Choi et al. [116] | |
Astragalin and tormentic acid | Inhibition of IkBα phosphorylation and degradation | An et al. [117] Cheng et al. [120] |
|
Antioxidant | Antioxidants (vitamin C, vitamin E, carotenoids, polyphenols and antioxidant enzymes) | Reduction of ROS production | Kirkeskov et al. [101] Schwager et al. [107] Jimenez et al. [21] |
Inhibition of NO release from macrophages | Kirkeskov et al. [101] Schwager et al. [107] Kim et al. [111] |
||
Protection against cell apoptosis, DNA and mitochondrial H2O2-induced damage and amyloid β peptide-induced oxidative injury | Choi et al. [112] Liu et al. [113] |
||
Aqueous extract | Inhibition of RANKL-induced osteoclastogenesis | Cheng et al. [120] |